Jeong-Han Kim

Jeong-Han Kim

Auto-generated profile, based on publicly available information

Jeong-Han Kim

Division of Infectious Diseases, Department of Internal Medicine, Ewha Womans University College of Medicine, Mokdong Hospital, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EKEu Suk Kim
Eu Suk Kim
BCBum Sik Chin
Bum Sik Chin
CKChang Kyung Kang
Chang Kyung Kang
NKNam Joong Kim
Nam Joong Kim
KYKang Yumin
Kang Yumin
OCon behalf of the Korea National Committee for Clinical Management of COVID-19
on behalf of the Korea National Committee for Clinical Management of COVID-19
Kim ES, et al. J Korean Med Sci. 2020 Feb;35(13):e142. https://doi.org/10.3346/jkms.2020.35.e142

9 November 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HKHyung-Jun Kim
Hyung-Jun Kim
DHDeokjae Han
Deokjae Han
JKJeong-Han Kim
Jeong-Han Kim
DKDaehyun Kim
Daehyun Kim
BHBeomman Ha
Beomman Ha
JHJoonNyung Heo
JoonNyung Heo
Background: Prioritizing patients in need of intensive care is necessary to reduce the mortality rate during the COVID-19 pandemic. Although several scoring methods have been introduced, many require laboratory or radiographic findings that are not always easily available. Objective: The purpose of this study was to develop a machine learning model that predicts the need for intensive care for patients with COVID-19 using easily obtainable characteristics—baseline demographics, comorbidities, and symptoms. Methods: A retrospective study was performed using a nationwide cohort in South Korea. Patients admitted to 100 hospitals from January 25, 2020, to June 3, 2020, were included. Patient information was collected retrospectively by the attending physicians in each hospital and uploaded to an online case report form. Variables that could be easily provided were extracted. The variables were age, sex, smoking history, body temperature, comorbidities, activities of daily living, and symptoms. The primary outcome was the need for intensive care, defined as admission to the intensive care unit, use of extracorporeal life support, mechanical ventilation, vasopressors, or death within 30 days of hospitalization. Patients admitted until March 20, 2020, were included in the derivation group to develop prediction models using an automated machine learning technique. The models were externally validated in patients admitted after March 21, 2020. The machine learning model with the best discrimination performance was selected and compared against the CURB-65 (confusion, urea, respiratory rate, blood pressure, and 65 years of age or older) score using the area under the receiver operating characteristic curve (AUC). Results: A total of 4787 patients were included in the analysis, of which 3294 were assigned to the derivation group and 1493 to the validation group. Among the 4787 patients, 460 (9.6%) patients needed intensive care. Of the 55 machine learning models developed, the XGBoost model revealed the highest discrimination performance. The AUC of the XGBoost model was 0.897 (95% CI 0.877-0.917) for the derivation group and 0.885 (95% CI 0.855-0.915) for the validation group. Both the AUCs were superior to those of CURB-65, which were 0.836 (95% CI 0.825-0.847) and 0.843 (95% CI 0.829-0.857), respectively. Conclusions: We developed a machine learning model comprising simple patient-provided characteristics, which can efficiently predict the need for intensive care among patients with COVID-19.

19 February 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SPSang-Won Park
Sang-Won Park
CLChang-Seop Lee
Chang-Seop Lee
JKJeong-Han Kim
Jeong-Han Kim
IBIn-Gyu Bae
In-Gyu Bae
CMChisook Moon
Chisook Moon
MOMyoung-Don Oh
Myoung-Don Oh
Severe fever with thrombocytopenia syndrome (SFTS) is emerging in Asian 3 countries, China, Japan and Korea, which are scrub typhus endemic areas, and its incidence is increasing. As the two infections overlap epidemiologically and clinically and the accessibility or sensitivity of diagnostic tests is limited, early clinical prediction may be useful for diagnostic and therapeutic purposes. Patients aged ≥16 years who were clinically suspected and laboratory-confirmed to be infected with Orientia tsutsugamushi or the SFTS virus in South Korea were enrolled. Clinical and laboratory parameters were compared. Scrub typhus was further subclassified according to the status of eschar and skin rash. An SFTS prediction scoring tool was generated based on a logistic regression analysis of SFTS compared with scrub typhus. The analysis was performed on 255 patients with scrub typhus and 107 patients with SFTS. At initial presentation, subjective symptoms except for gastrointestinal symptoms, were more prominent in scrub typhus patients. In addition to the characteristic eschar and skin rash, headache was significantly more prominent in scrub typhus, while laboratory abnormalities were more prominent in SFTS. Leukopenia (white blood cell count < 4000/mm3; odds ratio [OR] 30.13), thrombocytopenia (platelet count < 80,000 /mm3; OR 19.73) and low C-reactive protein (< 1 mg/dL; OR 67.46) were consistent risk factors for SFTS (all P < 0.001). A prediction score was generated using these 3 variables, and a score ≥ 2 had a sensitivity of 93.1% (95% confidence interval [CI], 87.9–96.4%) and a specificity of 96.1% (95% CI, 93.8–97.6%) for SFTS. This prediction scoring tool may be useful for differentiating SFTS from eschar- or skin rash-negative scrub typhus. It is a simple and readily applicable tool with potential for use in primary care settings.

28 August 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JKJeong-Han Kim
Jeong-Han Kim
EKEu Suk Kim
Eu Suk Kim
KJKang-Il Jun
Kang-Il Jun
HJHyungul Jung
Hyungul Jung
JBJi Hwan Bang
Ji Hwan Bang
SPSang-Won Park
Sang-Won Park
Tuberculosis (TB), especially extrapulmonary tuberculosis (EPTB), is an important cause of fever of unknown origin (FUO) in TB-burdened areas. Little information is known about patients with EPTB with clinical features presenting as FUO and about the factor of delaying the diagnosis. We retrospectively analyzed EPTB patients who were referred with FUO at 3 university-affiliated hospitals over 8 years (2010–2017). The subjects were assigned to groups of early diagnosis and delayed diagnosis within 3 days of an initial comprehensive evaluation from the referral. Clinical and laboratory variables were compared between the groups. A total of 95 patients with febrile EPTB were included. Localizing symptoms and/or signs suggestive of anatomy were identified in 62.1% of the patients. Concurrent lung involvement by TB was presented by 49.5% (47/95) of the patients, and only 23.4% of them showed typical findings of pulmonary TB on simple chest X-ray. Most of the patients showed abnormal lesions on cross-sectional CT (98.9%) and MRI (100%). The clinical variables and blood test results of patients were not significantly different between the two groups. The less typical imaging finding of EPTB on CT (38.5% vs. 79.0%) and MRI (37.5% vs. 79.0%) in the delayed diagnosis group was a risk factor for delayed diagnosis. Febrile EPTB referred as FUO showed nonspecific clinical manifestations. The active application of cross-sectional imaging tests according to clinical clues or randomly in the absence of local manifestations, combined with invasive diagnostic approaches even for atypical presentations may lead to an earlier diagnosis of febrile EPTB.

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
JKJeong-Han Kim
Jeong-Han Kim
CLChang-Seop Lee
Chang-Seop Lee
CMChisook Moon
Chisook Moon
YKYee Gyung Kwak
Yee Gyung Kwak
BKBaek-Nam Kim
Baek-Nam Kim
SPSang-Won Park
Sang-Won Park
Kim JH, et al. J Korean Med Sci. 2019 Sep;34(39):e257. https://doi.org/10.3346/jkms.2019.34.e257

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DHDae-Hyuk Heo
Dae-Hyuk Heo
JSJun-Won Seo
Jun-Won Seo
JKJeong-Han Kim
Jeong-Han Kim
JCJune Young Chun
June Young Chun
KJKang Il Jun
Kang Il Jun
HKHong Bin Kim
Hong Bin Kim
Heo DH, et al. J Korean Med Sci. 2019 Oct;34(43):e270. https://doi.org/10.3346/jkms.2019.34.e270